Results 141 to 150 of about 189,918 (307)
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon +9 more
wiley +1 more source
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee +8 more
wiley +1 more source
Linking bacterial life-history strategies and diversity to litter decomposition dynamics in a dry-hot valley area. [PDF]
Yang T +7 more
europepmc +1 more source
New Book Brings Chemistry To Life With Art, History, Humor
Beth Potier
openalex +1 more source
Tumor mutational burden as a determinant of metastatic dissemination patterns
This study performed a comprehensive analysis of genomic data to elucidate whether metastasis in certain organs share genetic characteristics regardless of cancer type. No robust mutational patterns were identified across different metastatic locations and cancer types.
Eduardo Candeal +4 more
wiley +1 more source
Training medical students' diagnostic reasoning skills using multivariate analysis. [PDF]
Schaberle FA +3 more
europepmc +1 more source
Debus, Allen G. (ed.): Alchemy and early modern chemistry. Papers from Ambix. Lindley, Jeremy Mills Publishing for the Society for the History of Alchemy and Chemistry, 2004. XV, 543 p. Ill. I 71.67. ISBN 0-9546484-1-2. [PDF]
Urs Leo Gantenbein
openalex +1 more source
Data base or Data repository? – A brief and very selective history of data management in chemistry.
Henry S. Rzepa
openalex +1 more source
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source

